ArticleRespiration; international review of thoracic diseases2026
Feasibility and Safety of a Robotic-Assisted Optical Navigation System for Pulmonary Nodule Percutaneous Cryoablation: A Prospective, Single-Center, Single-Arm Pilot Study.
Article in Respiration; international review of thoracic diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
<p>Introduction: Percutaneous cryoablation under imaging guidance is an effective therapeutic modality for pulmonary nodules, but the conventional technique relies on surgical complexity and physician experience. Computed tomography (CT)-guided robotic-assisted percutaneous puncture technique provides three-dimensional reconstruction, optimal needle trajectory planning, and monitoring of real-time respiratory motion, thereby enabling safe ablation of lung nodules. This study aimed to clinically evaluate the feasibility and safety of a robotic-assisted optical navigation system when utilized for CT-guided percutaneous cryoablation of pulmonary nodules.
methodsPatients who underwent CT-guided percutaneous cryoablation via a robotic-assisted optical navigation system were prospectively enrolled in our study. The primary outcomes were the technical success rate and the technical efficacy rate, and the preoperative, intraoperative, and postoperative variables were recorded and analyzed for each patient.
resultsA total of 37 consecutive patients with a single nodule were ultimately enrolled in the present study. The technical success rate was 100%, and the technical efficacy rate of robotic-assisted cryoablation was 100% with no recurrence during the 1-month follow-up. The average number of needle adjustments per nodule was 0.82 ± 1.19 in this study, with a mean deviation of 3.47 ± 2.47 mm. The mean numbers of CT acquisitions and dose length product used during needle insertion were 3.44 ± 1.65 and 638.86 ± 434.44 mGy cm, respectively. The duration of needle placement was 15.95 ± 5.06 min, whereas the total procedural duration was 99.32 ± 32.00 min. Notably, the deviation was found to be significantly correlated with the lobar location and was more prominent in the lower lobe. However, no significant correlations were observed with the nodule type, size, distance to the pleura, chest wall thickness, needle trajectory length, decubitus position, or the pulmonary function status of the patient. Moreover, no significant changes were found in the pulmonary function of the patients before or after the treatment. No major grade ≥3 complications were observed. However, among the minor complications, there were 5 cases (13.51%) of immediate pneumothorax, 2 cases (5.41%) of delayed pneumothorax, and 1 case (2.70%) of hemorrhage.
conclusionThe feasibility, safety, and preliminary effectiveness of robotic-assisted optical navigation system for CT-guided percutaneous cryoablation of pulmonary nodules were demonstrated; however, long-term efficacy and safety require further validation through multicenter, large-scale, prospective clinical studies with extended follow-up. </p>.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.